Exscientia to Report Third Quarter 2023 Financial Results on November 9, 2023

Rhea-AI Summary

Exscientia plc (Nasdaq: EXAI) will report financial results for the third quarter ended September 30, 2023, on November 9, 2023. The company will host a conference call and webcast at 1:30 p.m. GMT / 8:30 a.m. EST to provide a business update and review financial results. Investors can access the webcast on the company's website or join the conference call using the provided dial-in numbers.

Company to host conference call and webcast on November 9, 2023, at 1:30 p.m. GMT / 8:30 a.m. EST

OXFORD, England--(BUSINESS WIRE)-- Exscientia plc (Nasdaq: EXAI) will report financial results for the third quarter ended September 30, 2023, on Thursday, November 9, 2023, before the open of U.S. markets. The Company will host a conference call and webcast at 1:30 p.m. GMT / 8:30 a.m. EST to provide a business update and review financial results.

A webcast of the live call can be accessed by visiting the “Investors and Media” section of the Company’s website at investors.exscientia.ai. Alternatively, the live conference call can be accessed by dialing +1 (888) 330 3292 (U.S.), +44 203 433 3846 (U.K.), +1 (646) 960 0857 (International) and entering the conference ID: 8333895. A replay will be available for 90 days under “Events and Presentations” in the “Investors and Media” section of the Exscientia website.

About Exscientia

Exscientia is an AI-driven precision medicine company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Exscientia developed the first-ever functional precision oncology platform to successfully guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Our internal pipeline is focused on leveraging our precision medicine platform in oncology, while our partnered pipeline broadens our approach to other therapeutic areas. By pioneering a new approach to medicine creation, we believe the best ideas of science can rapidly become the best medicines for patients.

Visit us at https://www.exscientia.ai or follow us on X/Twitter @exscientiaAI.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231102371588/en/

Investor Relations:

Sara Sherman

investors@exscientia.ai

Media:

Oliver Stohlmann

media@exscientia.ai

Source: Exscientia plc

FAQ

When will Exscientia plc report its financial results for the third quarter of 2023?

Exscientia plc will report its financial results for the third quarter ended September 30, 2023, on November 9, 2023.

What time will the conference call and webcast take place?

The conference call and webcast will take place at 1:30 p.m. GMT / 8:30 a.m. EST.

How can investors access the webcast?

Investors can access the webcast by visiting the 'Investors and Media' section of the Exscientia website at investors.exscientia.ai.

How can investors join the conference call?

Investors can join the conference call by dialing +1 (888) 330 3292 (U.S.), +44 203 433 3846 (U.K.), +1 (646) 960 0857 (International) and entering the conference ID: 8333895.

Will there be a replay of the conference call available?

Yes, a replay of the conference call will be available for 90 days under 'Events and Presentations' in the 'Investors and Media' section of the Exscientia website.